Delivery Order SPE2DB20D1100-SPE2DB24FA4V8
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,652.09, is for the delivery of PROGRAF 1 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of January 19, 2024 and is a firm fixed-price delivery order. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,431.75 firm fixed-price delivery order is for the supply of PROGRAF 1 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of December 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,928.98, is a delivery order for the pharmaceutical product PROGRAF 1 MG CAPSULE 100S. The award has no set-aside designation, indicating full and open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $21,082.84 to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of 4565966189 - PROGRAF 1 MG CAPSULE 100S, a pharmaceutical product, with a period of performance through September 30, 2024. This contract award is part of a larger indefinite delivery contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up...
- This federal contract award, with the ID SPE2DB22D3019|SPE2DB24FK2TY, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $7,562.65 firm-fixed-price delivery order is for the pharmaceutical product PROGRAF 5 MG CAPSULE 100S. The contract has an ultimate completion date of November 30, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
- This federal contract award is for the delivery of pharmaceutical products, specifically PROGRAF 5 MG CAPSULE 100S, to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $17,498.89 and an ultimate completion date of May 4, 2023. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a delivery order (SPE2DB25FZ14B) valued at $25,634.40 for the supply of PROGRAF 1 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of November 20, 2024 and is a firm fixed-price contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency (DLA) awarded a $9,173.56 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PROGRAF 1 MG CAPSULE 100S, a pharmaceutical product, with a performance period ending on May 8, 2023. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves...
- The federal contract award, with ID SPE2DX15D1021|SPE2DX24FHNPM, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $1,236.24, is a delivery order for the pharmaceutical product PROGRAF 0.5 MG CAPSULE 100S. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has...
- This federal contract award, valued at $13,925.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of PROGRAF 1 MG CAPSULE 100S, a pharmaceutical product, with a completion date of October 24, 2024. The contract is structured as a Delivery Order under a Firm Fixed Price pricing type. No set-aside designation was used for this award. AmerisourceBergen holds a significant Indefinite Delivery...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FA4V8Delivery Order
This federal contract award was granted to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA). The contract, valued at $6,392.46, is a Delivery Order for the supply of PROGRAF 1 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of March 1, 2024, and uses a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 2/29/24 |